Accelerating Drug Discovery
with AI
The drug discovery cycle takes 10–15 years and costs billions. WeDaita was built to compress that timeline— giving researchers AI-native tools that eliminate bottlenecks from target identification to clinical insights.
Purpose-Built for Drug Discovery
To accelerate drug discovery by eliminating inefficiencies in biomedical research—unlocking faster, more scalable innovation through AI-native tools and integrated data workflows.
Delivers AI-driven solutions that address the core pain points of biomedical research: siloed data, manual analysis, fragmented workflows, and slow insight generation using our intelligent biomedical AI platform powered by advanced AI agents and WeDaita MCP services.
Three Pillars of BioMedAI
Every feature starts with a real scientific problem. We partner with researchers to ensure the platform reflects how biology actually works—not just how software is typically built.
Built on large language models, multi-agent orchestration, and WeDaita MCP services—so AI is the core reasoning layer, not a bolt-on feature on top of legacy software.
From target identification and database retrieval to ADME prediction and clinical trial analysis— a single connected workflow replacing dozens of fragmented tools.
Ready to See BioMedAI in Action?
Explore the full platform or book a live demo with our team and see how WeDaita compresses the drug discovery timeline for your organisation.